Physician profile
Mark Farrior
NPI 1194717942
$712.02
in general payments reported to CMS, 2019-2025
14 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2023: $195 · 2024: $200 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $583.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $143.15 | 2019-2024 | |
| Cranial Technologies, INC | $128.13 | 2019-2025 | Doc Band |
| Corium, LLC | $89.13 | 2023-2025 | Azstarys |
| Sanofi-Aventis U.S. LLC | $71.82 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $63.68 | 2019-2024 | Vaxelis, Gardasil 9, Vaxneuvance |
| Ironshore Pharmaceuticals INC. | $51.33 | 2019 | |
| Sanofi Pasteur INC. | $34.22 | 2023 | |
| Ironwood Pharmaceuticals, INC | $23.81 | 2024 | |
| Organon LLC | $19.90 | 2025 | Vtama |
| Acadia Pharmaceuticals INC | $19.82 | 2024 | Daybue |
| Alk-Abello, INC | $17.70 | 2025 | Neffy |
| Shire North American Group INC | $17.25 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.37 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $15.71 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Farrior listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.